Related Experiment Videos
Progression of paclitaxel-induced neuropathy following discontinuation of treatment
M J van den Bent1, V J van Raaij-van den Aarssen, J Verweij
1Department of Neuro-Oncology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Muscle & Nerve
|June 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Innovation in oncology clinical trial design.
Cancer treatment reviews·2019
Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug Development.
Hematology (Amsterdam, Netherlands)·2016
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials.
European journal of cancer (Oxford, England : 1990)·2015
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
Cancer chemotherapy and pharmacology·2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.
European journal of cancer (Oxford, England : 1990)·2014
Ultrasound-Guided Treatment of Peripheral Entrapment Mononeuropathies.
Muscle & nerve·2026
The Expanding Therapeutic Landscape in Myasthenia Gravis.
Muscle & nerve·2026
A novel nanoparticle-based co-delivery system of Fritillaria persica L. extract and gemcitabine for inhibiting breast cancer progression.
Beilstein journal of nanotechnology·2026